Session Description: 

This is a meeting of multiple medical disciplines to provide insight into the treatment of complex cases involving malignant lesions. Participants review of cases to assist in making collaborative decisions for these complex tumor cases utilizing NCCN guidelines. Review of best practice guidelines, current data, and emerging evidence provide educational opportunities to improve care plans and support optimal patient outcomes.

Target Audience: 

Physicians (MD or DO)

Learning Objectives:

After Attending this Activity, Learners Should be Able to:

1. Evaluate difficult or unique patient cases and engage in interprofessional collaboration in order to gain consensus and achieve an informed decision on the ideal treatment plan for each patient utilizing NCCN guidelines.

2. Review evidence related to the social determinants of health and the impact of implicit biases in oncology care in order to support culturally appropriate carefree from differential outcomes related to unconscious biases.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

  1. American Association for Cancer Research Cancer Disparities Progress Report (2022). https://cancerprogressreport.aacr.org/disparities/?utm_source=digital&utm_medium=sem&campaign=disparities-report&gclid=EAIaIQobChMIv4C_wIe8_QIVEx19Ch0l1AmjEAAYASAAEgIDDfD_BwE
  2. Mayden, K. (2021). Improving health equity: The role of the oncology advanced practitioner in managing implicit bias. Journal of the Advanced Practitioner in Oncology; 12(8): 868-874. doi: 10.6004/jadpro.2021.12.8.7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631340/
  3. Sarfati, D. (2019). Why social inequalities matter in the cancer continuum. Reducing social inequalities in Cancer: Evidence and Priorities for Research. https://www.ncbi.nlm.nih.gov/books/NBK566166/

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification:  Kerri Maya, PhD(c), MSL, RN, NPD-BC

Session date: 
05/27/2024 - 12:00pm to 1:00pm PDT
  • 1.00 AMA PRA Category 1 Credit

    In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.

    Jointly accredited provider, with commendation, interprofessional continuing education
  • 1.00 AMA PRA Category 1 CreditHour(s)

    In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 CreditHour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Jointly accredited provider, with commendation, interprofessional continuing education

Please login or register to take this course.